Koch's glycoside


William F. Koch, MD, PhD, a graduate of the University of Michigan developed a substance known as "synthetic anti-toxin," which later became known as "glyoxylide." The treatment was marketed under the label of the "Christian Medical Research League." Koch proposed that a single toxin caused cancer, and that the disease could be prevented or reversed by removing that toxin. To achieve this goal, Koch claimed he had developed glyoxylide, an oxygen compound that could be injected into patients' muscles. Koch and his followers asserted that glyoxylide forced cancer cells to absorb oxygen, which helped to clear the body of the cancer-causing toxin.
Koch theorized that cancer formed because of a metabolic defect brought on by a toxin or injury, making it incapable to burn off such toxins. His anti-toxin, glyoxylide, made use of an oxidizing catalyst to burn off toxins that might otherwise become cancerous.
The Journal of the American Medical Association (JAMA) denounced Koch as a quack after he refused to sell his protocol to the American Medical Association (AMA). At the instigation of the AMA, the Food and Drug Administration (FDA) put him on trial in 1942 and 1946. They did not succeed in getting a conviction, but neither could Koch secure an acquittal. When the FDA finally dismissed the indictment in 1948, Koch moved to Brazil. He never revealed his manufacturing process. Koch's one-shot cancer therapy died with him.
Koch researched, invented and patented a system of treatments with reagents that used chemicals to restore the body's oxidation mechanism, thus allowing the body to heal itself back to its original vitality, thereby re-equipping the body with its innate ability to restore and maintain health, not only in cancers but also in a host of its 'allied diseases.'
Today researchers have shown the value of many oxygen-yielding protocols (such as hydrogen peroxide and ozone therapy) for treating various disease processes.

Related Terms

Autohemotherapy, bio-oxidative therapy, germanium sesquioxide, glyoxylide, hydrogen peroxide (H2O2) therapy, hyperoxygenation, Koch, Koch's glyoxylide, malonide, oxidative therapy, oxidology, oxymedicine, ozone (O3) therapy, parabenzoquinone.